cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Ahmad Subhan
Contact Email
jurnal.rsf@gmail.com
Phone
+6281270987241
Journal Mail Official
jurnal@rsupfatmawati.co.id
Editorial Address
Instalasi Pengelolaan Inovasi dan Kekayaan Intelektual (IPIKI) RSUP Fatmawati Jl.RS Fatmawati No.1 Cilandak, Jakarta Selatan, Indonesia Telp : 021-7501524 ext.1425 Email : jurnal@rsupfatmawati.co.id
Location
Kota adm. jakarta selatan,
Dki jakarta
INDONESIA
Jurnal Farmasi Klinik - Best Practice (JFKlin)
Published by Rumah Sakit Umum Pusat Fatmawati
ISSN : 3032467X     EISSN : 29647584     DOI : 10.58815
Core Subject : Health, Science,
Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health
Jurnal Farmasi Klinik - Base Practice (JFKlin) is a peer-reviewed journal published by RSUP Fatmawati. It focus on the field of health sciences with the specialty of pharmaceutical sciences, pharmaceutical services in hospitals and community. JFKlin has been published twice a year in Indonesian and started from 2022 JFKlin will be fully published in Open Journal System (OJS).
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Farmakologi
Articles 33 Documents
 1   2   3   4 
The Evaluasi Penggunaan Obat Kemoterapi Pada Pasien Kanker Ovarium Di RSUP Fatmawati Periode September 2024. Raden, Ditaa
Jurnal Farmasi Klinik Best Practice Vol 4 No 1 (2025): Jurnal Farmasi Klinis Best Practice Volume 4 No. 1 Juni 2025
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v4i1.57

Abstract

Ovarian cancer is a major malignancy in the female reproductive system. Treatment for this cancer can involve surgical procedures or the use of chemotherapy drugs, either orally or intravenously. This study was conducted to evaluate the use of chemotherapy drugs in ovarian cancer patients at RSUP Fatmawati. Data collection was carried out through a retrospective observation by gathering information on drug usage from the patients' medical records, which included data from 31 patients receiving treatment at RSUP Fatmawati in September 2024. Based on the obtained data, it was found that the most commonly used chemotherapy drug for cancer patients at RSUP Fatmawati is TAC (Paclitaxel + Carboplatin), accounting for 80.65%. Additionally, based on the chemotherapy regimens used at RSUP Fatmawati, the recovery percentage from several regimens ranged from 54.90% to 131.93%.
STUDI KASUS EFEK SAMPING DIABETES MELITUS, HIPERTENSI, DAN INFEKSI PADA PASIEN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DENGAN PENEKAN IMUN METILPRENISOLON Wan Yik Sin, Cindy; Magdalena Niken Oktovina; Imam Adi Wicaksono
Jurnal Farmasi Klinik Best Practice Vol 4 No 1 (2025): Jurnal Farmasi Klinis Best Practice Volume 4 No. 1 Juni 2025
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v4i1.60

Abstract

Systemic Lupus Erythematosus (SLE) merupakan penyakit autoimun kompleks yang menyerang berbagai sistem tubuh. Penyakit ini ditandai dengan pembentukan autoantibodi patogenik terhadap asam nukleat dan protein pengikatnya akibat adanya intoleransi terhadap komponen tubuh. Pasien SLE membutuhkan penekan imun untuk mengurangi inflamasi akibat autoantibodi tersebut serta digunakan berkepanjangan untuk mencegah perburukan kondisi dan mengurangi resiko kekambuhan. Salah satu obat penekan imun yang menjadi tatalaksana penyakit SLE ialah kortikosteroid seperti metilprednisolon (MP). Sayangnya, walaupun terdapat penggunaan regimen obat MP, namun penggunaan MP jangka panjang dapat meningkatkan resiko munculnya berbagai Efek Samping Obat (ESO). Efek samping MP yang dialami salah satu pasien di Rumah Sakit (RS) Fatmawati meliputi diabetes, hipertensi, dan infeksi. Dari hasil studi kasus tersebut, mekanisme ESO yang terjadi meliputi efek mineralokortikoid dan juga glukokortikoid dari kortikosteroid. Kerusakan organ dan perubahan fisiologi tubuh merupakan mekanisme utama dari efek tersebut. Upaya meminimalisasi ESO pada penggunaan MP jangka panjang meliputi penggunaan dosis minimal yang efektif, prinsip tappering off, dan penggunaan steroid-sparing-agent perlu diupayakan untuk meminimalisasi efek samping tersebut.
Pengelolaan Obat High Alert, LASA (Look-Alike Sound-Alike), Emergensi, dan Obat Umum di Farmasi RSUP Fatmawati Suaif, Suaif
Jurnal Farmasi Klinik Best Practice Vol 4 No 1 (2025): Jurnal Farmasi Klinis Best Practice Volume 4 No. 1 Juni 2025
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v4i1.63

Abstract

Proper management of drug storage in hospitals is essential for ensuring quality and patient safety, particularly for high-alert drugs, look-alike sound-alike (LASA) drugs, and emergency drugs. This study evaluates the storage system for these drugs in the Fatmawati Hospital Pharmacy Warehouse according to the PKPO and SKP standards established by the Indonesian Ministry of Health. The evaluation was conducted through direct observation, a document study, and a comparison to Permenkes and Kepmenkes standards. The results show that, while most of the storage system is appropriate, there are still non-conformities, such as high-alert drugs being placed outside the red zone, suboptimal LASA marking, and limited warehouse space. The study recommended improvements to the marking zone, staff training, and layout arrangements. The results showed that 94% of high-alert drug storage was in the excellent category, 70% of LASA drug storage was in the good category, 80% of trolley emergency drug storage was in the good category, and 85.14% of general drug storage was in the good category. Statistical analysis using a t-test revealed that the storage of high-alert, LASA, emergency, and general drugs had a significance value of p > 0.05. These results illustrate that drug storage in the Fatmawati Hospital Pharmacy warehouse meets the standards. Keywords: Medication Storage, High-Alert Medications, LASA, Emergency Medications, Pharmaceutical Warehouse.

Page 4 of 4 | Total Record : 33

 1   2   3   4 

Filter by Year

2022 2025


Reset
Filter By Issues
All Issue Vol 4 No 1 (2025): Jurnal Farmasi Klinis Best Practice Volume 4 No. 1 Juni 2025 Vol 3 No 2 (2024): Jurnal Farmasi Klinis Best Practice Volume 3 No. 2 Desember 2024 Vol 3 No 1 (2024): Jurnal Farmasi Klinis Best Practice Volume 3 No. 1 Juni 2024 Vol 2 No 2 (2023): Jurnal Farmasi Klinik Best Practice Vol 2 No 1 (2023): Jurnal Farmasi Klinik Best Practice Vol 1 No 1 (2022): Jurnal Farmasi Klinik - Best Practice